252 related articles for article (PubMed ID: 34518579)
1. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin.
Chennampally P; Sayed-Zahid A; Soundararajan P; Sharp J; Cox GA; Collins SD; Smith RL
Sci Rep; 2021 Sep; 11(1):18168. PubMed ID: 34518579
[TBL] [Abstract][Full Text] [Related]
2. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.
Huang C; Tong J; Bi F; Zhou H; Xia XG
J Clin Invest; 2012 Jan; 122(1):107-18. PubMed ID: 22156203
[TBL] [Abstract][Full Text] [Related]
3. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP.
Cheng CW; Lin MJ; Shen CK
J Neurogenet; 2015; 29(2-3):59-68. PubMed ID: 26219309
[TBL] [Abstract][Full Text] [Related]
5. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice.
Herdewyn S; Cirillo C; Van Den Bosch L; Robberecht W; Vanden Berghe P; Van Damme P
Mol Neurodegener; 2014 Jun; 9():24. PubMed ID: 24938805
[TBL] [Abstract][Full Text] [Related]
6. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
7. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth.
Fallini C; Bassell GJ; Rossoll W
Hum Mol Genet; 2012 Aug; 21(16):3703-18. PubMed ID: 22641816
[TBL] [Abstract][Full Text] [Related]
8. A robust TDP-43 knock-in mouse model of ALS.
Huang SL; Wu LS; Lee M; Chang CW; Cheng WC; Fang YS; Chen YR; Cheng PL; Shen CJ
Acta Neuropathol Commun; 2020 Jan; 8(1):3. PubMed ID: 31964415
[TBL] [Abstract][Full Text] [Related]
9. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
10. Disulfide cross-linked multimers of TDP-43 and spinal motoneuron loss in a TDP-43
Bargsted L; Medinas DB; Martínez Traub F; Rozas P; Muñoz N; Nassif M; Jerez C; Catenaccio A; Court FA; Hetz C; Matus S
Sci Rep; 2017 Oct; 7(1):14266. PubMed ID: 29079747
[TBL] [Abstract][Full Text] [Related]
11. A high-fat jelly diet restores bioenergetic balance and extends lifespan in the presence of motor dysfunction and lumbar spinal cord motor neuron loss in TDP-43A315T mutant C57BL6/J mice.
Coughlan KS; Halang L; Woods I; Prehn JH
Dis Model Mech; 2016 Sep; 9(9):1029-37. PubMed ID: 27491077
[TBL] [Abstract][Full Text] [Related]
12. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
13. GPNMB ameliorates mutant TDP-43-induced motor neuron cell death.
Nagahara Y; Shimazawa M; Ohuchi K; Ito J; Takahashi H; Tsuruma K; Kakita A; Hara H
J Neurosci Res; 2017 Aug; 95(8):1647-1665. PubMed ID: 27935101
[TBL] [Abstract][Full Text] [Related]
14. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
[TBL] [Abstract][Full Text] [Related]
15. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
16. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis.
Estes PS; Daniel SG; McCallum AP; Boehringer AV; Sukhina AS; Zwick RA; Zarnescu DC
Dis Model Mech; 2013 May; 6(3):721-33. PubMed ID: 23471911
[TBL] [Abstract][Full Text] [Related]
17. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
Wächter N; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
[TBL] [Abstract][Full Text] [Related]
18. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
19. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice.
Qiu L; Qiao T; Beers M; Tan W; Wang H; Yang B; Xu Z
Mol Neurodegener; 2013 Jan; 8():1. PubMed ID: 23281774
[TBL] [Abstract][Full Text] [Related]
20. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
